LIMK1 and breast carcinoma: It has been reported that Lnc-408 upregulates LIMK1 signaling pathway via sponging miR-654-5p, thereby accelerating breast cancer metastasis and invasion [28], and Lnc-MT1JP has been proved to enhance the resistance of hepatocellular carcinoma cells to Lenvatinib via sponging miR-24-3p [29].